Proteomic Profiling Identifies Distinct Protein Patterns in Acute Myelogenous Leukemia CD34+CD38- Stem-Like Cells-Reference-Cited by-同舟云学术

Proteomic Profiling Identifies Distinct Protein Patterns in Acute Myelogenous Leukemia CD34+CD38- Stem-Like Cells

Published:2013-10-24 Issue:10 Volume:8 Page:e78453
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kornblau Steven M.,Qutub Amina,Yao Hui,York Heather,Qiu Yi Hua,Graber David,Ravandi Farhad,Cortes Jorge,Andreeff Michael,Zhang Nianxiang,Coombes Kevin R.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference53 articles.

1. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell;D Bonnet;Nat Med,1997

2. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells;LW Terstappen;Blood,1991

3. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice;T Lapidot;Nature,1994

4. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells;HJ Sutherland;Blood,1996

5. Identification of a Small Subpopulation of Candidate Leukemia Initiating Cells in the Side Population (SP) of Patients with Acute Myeloid Leukemia;B Moshaver;Stem Cells,2008

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. System analysis of Huang-Lian-Jie-Du-Tang and their key active ingredients for overcoming CML resistance by suppression of leukemia stem cells;Phytomedicine;2023-08

2. Proteomic and phosphoproteomic landscapes of acute myeloid leukemia;Blood;2022-09-29

3. c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia;Apoptosis;2022-08-09

4. Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias;Biomedicines;2022-07-30

5. Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients;Cancers;2022-07-22